Skip to content

Clinical trials

Phase 2 Coronary Artery Disease trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Artery Disease Phase: Phase 2 Country / region: Belgium Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20052
20101
20114
20121
20132
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Micell Technologies2
Universitaire Ziekenhuizen KU Leuven2
Antwerp Cardiovascular Institute Middelheim1
Bayer1
Elixir Medical Corporation1
Fluoropharma, Inc.1
GlaxoSmithKline1
OrbusNeich1
Resverlogix Corp1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease13
Atherosclerosis3
Angina, Unstable2
Acute Coronary Syndrome1
Angina, Stable1
Cardiovascular Diseases1
Coronary Disease1
Myocardial Infarction1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.